ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma
Blood Test Could Predict Relapse, Survival For Children, Young Adults With Leukemia
Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO
Phase II Study Finds Dasatinib May Overcome ALL Resistance
Sarcoma Survivors At Risk Of Blood Clots, Study Finds
Risk of Lymphoma Increases with Hepatitis C Virus Infection
Long-Term Results Find Cisplatin Improves Survival
Study Links Ovarian Cancer To Hormone Replacement
Smokers Who Quit Live Longer Than Those Who Spit-Study
FDA Approves New Drug for Advanced Kidney Cancer
FDA Approves New Indication For Anticoagulant Frangmin
NCI-Approved Group, Center Clinical Trials Listed
Trending Stories
- As Trump’s second term nears, Republican support for NIH is at a low point
By stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research - As Trump’s HHS pick, RFK Jr. stands to honor or squander the Kennedy legacy in cancer
- Trump 2016: A look back at the 45th president’s impact on oncology
- Cedars-Sinai spearheads first national certification program for COE staff at cancer centers
- Menin inhibitors emerge as new treatment for advanced AML
- Patient navigation benefits health systems, improves care
Initial data presented at the White House come a year after CMS payment began
